# Urology Consultation

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Benjamin Franklin (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EN004-SYN
- Date: 2026-03-30
- Fictional facility: St. Posthumous Health Center
- Fictional author: Mateo Ibarra, MD
- Calendar frame: modern shifted

- Requested by: Lydia Penhallow, MD

## Reason for consultation

Bladder stone with hematuria and obstructive voiding symptoms in a 76-year-old man with gout and stage 3a chronic kidney disease. Please confirm the diagnosis, remove the stone, look for its cause and for other sources of the bleeding, and advise on preventing recurrence. **S**

## History

Mr. Franklin is seen at the request of Dr. Penhallow for a bladder stone found on CT. For several years he has had a slow stream and nocturia, and for two months an interrupted stream, pain at the end of voiding that is worse after walking or car travel, and pink urine. He has had no fever, retention, or urinary infections. He has recurrent gout and started allopurinol four weeks ago. He has never smoked and has no history of pelvic radiation or occupational dye exposure. **S**

## Examination

| System | Finding |
|---|---|
| Abdomen | Mild suprapubic tenderness; bladder not palpable |
| Genitalia | Normal; no meatal stenosis |
| Rectal | Smooth, symmetric, moderately enlarged prostate, about 55 mL, without nodules |
| Cystoscopy | Single large mobile bladder stone; trabeculated bladder; obstructing lateral lobes with a median lobe; no bladder tumor or carcinoma in situ appearance |

BP 138/80 mmHg; pulse 70 bpm; respirations 16/min; temperature 36.6 °C; oxygen saturation 97% on room air; weight 95.4 kg; BMI 31.2 kg/m². All vital signs are synthetic.

## Data reviewed

The non-contrast CT, intake urinalysis, serum urate and kidney function, and today's IPSS, uroflowmetry, bladder ultrasound for residual, and office flexible cystoscopy. Serum urate: 7.6 mg/dL (high); Sodium: 139 mmol/L; Potassium: 4.4 mmol/L; Bicarbonate (total CO2): 24 mmol/L; BUN: 21 mg/dL; Creatinine: 1.34 mg/dL; eGFR: 55 mL/min/1.73 m² (low); Glucose: 96 mg/dL; Post-void residual volume by bladder ultrasound: 160 mL (high); Maximum urine flow rate (Qmax): 8.5 mL/s (low); IPSS: 16. All results are synthetic.

## Assessment

1. **Bladder stone** (N21.0). Confirmed: a single 2.6 cm stone. Its low density on CT, his acidic urine, and his gout make uric acid the probable composition. It should be removed. **S**
2. **Bladder outlet obstruction from benign prostatic hyperplasia** (N40.1). Maximum flow 8.5 mL/s, residual 160 mL, IPSS 16, and a trabeculated bladder with an obstructing median lobe. Obstruction is the probable cause of the stone, and a bladder stone caused by obstruction is an indication for surgery, so both should be treated at one operation. **S**
3. **Hematuria**. Explained by the stone; cystoscopy shows no tumor, and CT shows no kidney or ureteric lesion. Repeat urinalysis after treatment; further imaging only if hematuria persists. **S**
4. **Chronic kidney disease G3a** (N18.31). No hydronephrosis; avoid NSAIDs and nephrotoxic contrast around surgery. **S**

## Recommendations

1. Transurethral laser cystolitholapaxy with transurethral resection of the prostate at one operation in about three weeks; send the stone for analysis and the tissue for pathology.
2. Tamsulosin 0.4 mg at bedtime until surgery to ease voiding.
3. No PSA test: at 76 it would not change management, and the resected tissue will be examined.
4. After surgery, repeat urinalysis for red cells and pH, and a 24-hour urine collection for volume, uric acid, citrate, and calcium.
5. If the stone is uric acid: fluids for at least 2.5 L of urine a day, potassium citrate to a urine pH of 6.0 to 6.5 with potassium monitoring because of losartan and kidney disease, and continued allopurinol titration.
6. Check IPSS and post-void residual about one, three, and six months after surgery.

## Strengths and supports

- Supports: family nearby, a wide circle of friends and correspondents, and a regular chess partner **S**

## Communication

Discussed with Dr. Penhallow the same day; the patient agrees and asked for a written explanation of the operation. **S**

## Follow-up

Urology performs the operation and the post-operative check. Primary care manages urate lowering, stone prevention, and kidney and blood pressure monitoring. Return to urology for recurrent stones, hematuria, retention, or worsening symptoms. **S**

## Guideline basis

- Medical Management of Kidney Stones: AUA Guideline (2014, amended 2019), American Urological Association
- EAU Guidelines on Urolithiasis (including bladder stones) (2025), European Association of Urology
- Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2023 amendment), American Urological Association
- CMID: Clinical Monitoring Intelligence Database, hypertension, chronic kidney disease, and benign prostatic hyperplasia monographs (2026), Aether Forge
